Published in Aging (Albany NY) on October 05, 2016
Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (2009) 190.94
A method and server for predicting damaging missense mutations. Nat Methods (2010) 78.53
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res (2010) 43.51
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med (2000) 25.49
Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet (1999) 18.22
pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics (2011) 16.75
Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer (2010) 10.61
Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science (1989) 9.71
International variation in prostate cancer incidence and mortality rates. Eur Urol (2012) 8.04
Punctuated evolution of prostate cancer genomes. Cell (2013) 7.23
Quality-of-life effects of prostate-specific antigen screening. N Engl J Med (2012) 7.21
Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics (2012) 5.04
Mitochondria and cancer. Nat Rev Cancer (2012) 4.81
The Molecular Taxonomy of Primary Prostate Cancer. Cell (2015) 3.29
Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. JAMA (2014) 2.42
Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet (1992) 2.17
North American white mitochondrial haplogroups in prostate and renal cancer. J Urol (2006) 2.13
MITOMAP: a human mitochondrial genome database. Nucleic Acids Res (1996) 1.75
Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients. Am J Hum Genet (2010) 1.67
Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer. Br J Cancer (2009) 1.59
Extensive somatic mitochondrial mutations in primary prostate cancer using laser capture microdissection. Cancer Res (2002) 1.53
Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer. Elife (2014) 1.39
Increased distributional variance of mitochondrial DNA content associated with prostate cancer cells as compared with normal prostate cells. Prostate (2008) 1.29
Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancer. Urol Oncol (2014) 1.16
Mitochondrial genome deletion aids in the identification of false- and true-negative prostate needle core biopsy specimens. Am J Clin Pathol (2008) 1.15
Prostate carcinoma presentation, diagnosis, and staging: an update form the National Cancer Data Base. Cancer (2003) 1.15
The mitochondrial and autosomal mutation landscapes of prostate cancer. Eur Urol (2012) 1.12
Identification of somatic and germline mitochondrial DNA sequence variants in prostate cancer patients. Mutat Res (2006) 1.10
Introduction to the molecular basis of cancer metabolism and the Warburg effect. Mol Biol Rep (2015) 0.85
Prevalence of mitochondrial DNA haplogroups in an Australian population. Intern Med J (2006) 0.84
Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening. Clin Cancer Res (2015) 0.80
Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy. Eur Urol (2015) 0.79
No Association between the Mitochondrial Genome and Prostate Cancer Risk: The Multiethnic Cohort. Cancer Epidemiol Biomarkers Prev (2016) 0.77
Mitochondrial DNA somatic mutation in cancer. Toxicol Res (2014) 0.77
Spectrum of mitochondrial genomic variation and associated clinical presentation of prostate cancer in South African men. Prostate (2015) 0.77
No association between typical European mitochondrial variation and prostate cancer risk in a Spanish cohort. J Hum Genet (2014) 0.76